Parimal Nathwani received his M.Sc. from the University of British Columbia and his M.B.A. from Simon Fraser University.
He has a decade of experience in various aspects of the biotechnology industry, including finance, intellectual property management, business development and operations; he has been actively involved in preparing business plans, forming start-up companies, raising early-stage capital, managing intellectual-property portfolios and out-licensing initiatives.
Most recently, Parimal was a healthcare analyst with a boutique investment bank, where he conducted due diligence on publicly-traded biotechnology companies in Canada and the U.S. for an institutional investor client base and advised companies on financing strategies. He has also held the position of technology transfer manager in the life sciences at one of Canada’s leading technology transfer offices.